Newborn screening initiatives for sickle cell disease in Africa

2.

Vichinsky

E

,

Hurst

D

,

Earles

A

,

Kleman

K

,

Lubin

B.

Newborn screening for sickle cell disease: effect on mortality

.

Pediatrics

.

1988

;

81

(

6

):

749

-

755

.

3.

Charache

S

,

Barton

FB

,

Moore

RD

, et al.

Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive “switching” agent. The multicenter study of hydroxyurea in sickle cell anemia

.

Medicine (Baltimore)

.

1996

;

75

(

6

):

300

-

326

.

4.

Adams

RJ

,

McKie

VC

,

Brambilla

D

, et al.

Stroke Prevention Trial in Sickle Cell Anemia

.

Control Clin Trials

.

1998

;

19

(

1

):

110

-

129

.

5.

Olney

RS

. Newborn screening for sickle cell disease: public health impact and evaluation. In:

Genetics and Public Health in the 21st Century

.

Oxford University Press

;

2000

:

431

-

446

.

6.

Adamkiewicz

TV

,

Silk

BJ

,

Howgate

J

, et al.

Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life

.

Pediatrics

.

2008

;

121

(

3

):

562

-

569

.

7.

Piel

FB

,

Rees

DC

,

DeBaun

MR

, et al.

Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission

.

Lancet Haematol

.

2023

;

10

(

8

):

e633

-

e686

.

. https://apps.who.int/iris/handle/10665/1682.

8.

World Health Organization

.

Sickle-cell disease: a strategy for the WHO African Region

. Accessed

2

May

2022

9.

World Health Organization Regional Committee for Africa

.

Progress in the implementation of the African Region sickle-cell strategy 2010-2020: information document

. AFR/RC70/INF.DOC/3.

30

July

2020

. https://iris.who.int/handle/10665/334098.

10.

Therrell

BL

,

Padilla

CD

,

Borrajo

GJC

, et al.

Current status of newborn bloodspot screening worldwide 2024: a comprehensive review of recent activities (2020-2023)

.

Int J Neonatal Screen

.

2024

;

10

(

2

):

38

.

11.

Reddy

MN

,

Franciosi

RA

.

Rapid quantitation of hemoglobin S by isoelectric focusing

.

Ann Clin Lab Sci

.

1994

;

24

(

5

):

401

-

406

.

12.

Fisher

SI

,

Haga

JA

,

Castleberry

SM

,

Hall

RB

,

Thompson

WC

.

Validation of an automated HPLC method for quantification of hemoglobin S

.

Clin Chem

.

1997

;

43

(

9

):

1667

-

1669

.

13.

Pant

L

,

Kalita

D

,

Singh

S

, et al.

Detection of abnormal hemoglobin variants by HPLC method: common problems with suggested solutions

.

Int Sch Res Notices

.

2014

;

2014

:

257805

.

14.

Chen

FT

,

Liu

CM

,

Hsieh

YZ

,

Sternberg

JC

.

Capillary electrophoresis–a new clinical tool

.

Clin Chem

.

1991

;

37

(

1

):

14

-

19

.

15.

Cotton

F

,

Wolff

F

,

Gulbis

B.

Automated capillary electrophoresis in the screening for hemoglobinopathies

.

Methods Mol Biol

.

2013

;

984

:

227

-

235

.

16.

Kuhn R

HKS

.

Capillary Electrophoresis: Principles and Practice

.

Springer Science and Business Media

.

2013

Mar

7

.

17.

Arishi

WA

,

Alhadrami

HA

,

Zourob

M.

Techniques for the detection of sickle cell disease: a review

.

Micromachines (Basel)

.

2021

;

12

(

5

).

18.

Kanter

J

,

Telen

MJ

,

Hoppe

C

,

Roberts

CL

,

Kim

JS

,

Yang

X.

Validation of a novel point of care testing device for sickle cell disease

.

BMC Med

.

2015

;

13

:

225

.

19.

Chindima

N

,

Nkhoma

P

,

Sinkala

M

, et al.

The use of dried blood spots: a potential tool for the introduction of a neonatal screening program for sickle cell anemia in Zambia

.

Int J Appl Basic Med Res

.

2018

;

8

(

1

):

30

-

32

.

20.

Nnodu

O

,

Isa

H

,

Nwegbu

M

, et al.

HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: promises and challenges

.

Blood Cells Mol Dis

.

2019

;

78

:

22

-

28

.

21.

Oluwole

EO

,

Adeyemo

TA

,

Osanyin

GE

,

Odukoya

OO

,

Kanki

PJ

,

Afolabi

BB

.

Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-a pilot study

.

PLoS One

.

2020

;

15

(

12

):

e0242861

.

22.

Okeke

CO

,

Chianumba

RI

,

Isa

H

,

Asala

S

,

Nnodu

OE

. Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria.

Front Genet

.

2022

;

13

:

1013858

.

23.

Olaniyan

HS

,

Briscoe

C

,

Muhongo

M

, et al.

Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests

.

Blood Adv

.

2023

;

7

(

19

):

5860

-

5867

.

24.

Guindo

A

,

Cisse

Z

,

Keita

I

, et al.

Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: a comparative diagnostic performance study of two rapid diagnostic tests (SickleSCAN ® and HemoTypeSC ®) on cord blood

.

Br J Haematol

.

2024

;

204

(

1

):

337

-

345

.

doi: 10.1111/bjh.19108

.

25.

Hasan

MN

,

Fraiwan

A

,

An

R

, et al.

Paper-based microchip electrophoresis for point-of-care hemoglobin testing

.

Analyst

.

2020

;

145

(

7

):

2525

-

2542

.

26.

Piety

NZ

,

Yang

X

,

Kanter

J

,

Vignes

SM

,

George

A

,

Shevkoplyas

SS

.

Validation of a low-cost paper-based screening test for sickle cell anemia

.

PLoS One

.

2016

;

11

(

1

):

e0144901

.

27.

Therrell

BL

Jr,

Hannon

WH

,

Bailey

DB

Jr, et al.

Committee report: considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening

.

Genet Med

.

2011

;

13

(

7

):

621

-

624

.

28.

Chace

DH

,

Hannon

WH

.

Filter paper as a blood sample collection device for newborn screening

.

Clin Chem

.

2016

;

62

(

3

):

423

-

425

.

29.

Cheryl

H

,

Jeffrey

B

,

Michele

C

, et al.

Residual Dried Blood Spot Specimens Educational Toolkit

. Updated APHL DBS Policy Statement A of PHL, editor.

2018

.

30.

Archer

NM

,

Inusa

B

,

Makani

J

, et al.

Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries

.

BMJ Open

.

2022

;

12

:

57623

.

31.

Bukini

D

,

Nkya

S

,

McCurdy

S

, et al.

Perspectives on building sustainable newborn screening programs for sickle cell disease: experience from Tanzania

.

Int J Neonatal Screen

.

2021

;

7

(

1

):

12

.

32.

Segbefia

CI

,

Goka

B

,

Welbeck

J

, et al.

Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: results and lessons learned

.

Pediatr Blood Cancer

.

2021

;

68

(

7

):

e29068

.

doi: 10.1002/pbc.29068

.

33.

Nnodu

OE

,

Adegoke

SA

,

Ezenwosu

OU

, et al.

A multi-centre survey of acceptability of newborn screening for sickle cell disease in Nigeria

.

Cureus

.

2018

;

10

(

3

):

e2354

.

34.

McGann

PT

,

Ferris

MG

,

Ramamurthy

U

, et al.

A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola

.

Am J Hematol

.

2013

;

88

(

12

):

984

-

989

.

35.

Hernandez

AG

,

Kiyaga

C

,

Howard

TA

, et al.,

Operational analysis of the national sickle cell screening programme in the Republic of Uganda

.

Afr J Lab Med

.

2021

;

10

(

1

):

1303

.

36.

Nkya

S

,

Mtei

L

,

Soka

D

, et al.

Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania

.

Int Health

.

2019

;

11

(

6

):

589

-

595

.

37.

McGann

PT

.

Time to invest in sickle cell anemia as a global health priority

.

Pediatrics

.

2016

;

137

(

6

):

e20160348

.